Collectively, these results indicate that ZD55-SATB1 combined with DTX may inhibit prostate cancer growth by inducing apoptosis and inhibit prostate cancer invasion and metastasis by reversing EMT. The gene discussed is SATB1; the disease is prostate carcinoma.